O225 - TREATMENT DE-INTENSIFICATION FOR WNT MEDULLOBLASTOMA: RESULTS FROM THE LOW-RISK ARM OF THE SIOP-PNET5-MB STUDY

• Autoři: DOZ François; MYNAREK Martin; MOSSERI Véronique; HORAN Gail; AVULA Shivaram; PFISTER Stefan; MASLIASH-PLANCHON Julien; PADOVANI Laetitia; BRISSE Herve; PIETSCH Torsten; BULL Kim; OBRECHT-STURM Denise; RIECHERS Regine; BENESCHC Martin; JACOBS Sandra; ŠTĚRBA Jaroslav; ET All
• Rok publikování: 2025
• Druh: Konferenční abstrakty
• Fakulta / Pracoviště MU: Lékařská fakulta

Přiložené soubory

• _3452_PNET5_MB_TREATMENT_DE-INTENSIFICATION_FOR...ESULTS_FROM_THE_LOW-RISK_ARM.pdf

• Popis: Background and Aims WNT group medulloblastomas have a favourable prognosis. The low risk stratum (phase II) of the European SIOP PNET5 MB trial aimed to prospectively confirm the good prognosis for children <16 years old with WNT group localized medulloblastoma, residual disease <1.5 cm2, and classic histology, when treated with reduction of both craniospinal irradiation (CSI) and chemotherapy.